Maze Therapeutics to Present at Guggenheim Emerging Outlook: Biotech Summit 2026
I'm PortAI, I can summarize articles.
Maze Therapeutics Inc. will present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 11, 2026. CEO Jason Coloma, Ph.D., is scheduled to speak, and a live webcast will be available on the company's website, archived for 60 days post-event. This news was generated by Public Technologies and is for informational purposes only, not financial or legal advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments